GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Theriva Biologics TOVX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.17

-0.42%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Theriva Biologics

Our reporting

We have not reported on Theriva Biologics yet.

Next results

11 Nov 2026

Due on 11 Nov 2026.

Past results

Reported against what analysts expected

11 Aug 20265 May 202612 Mar 202612 Nov 202511 Aug 202524 Mar 2025
Earnings per share-0.07-0.051.85-0.45-1.936.03
Forecast-0.06-0.05-0.43-0.38-0.38-7.22
Revenue—$300,000————
Forecast—$300,000————

Key events

  1. 26 Aug 202425-to-1 reverse split
  2. 25 Jul 202210-to-1 reverse split
  3. 13 Aug 201835-to-1 reverse split
  4. 25 Apr 20073-to-1 reverse split
  5. 3 Oct 2005250-to-1 reverse split
  6. 12 Feb 1993Listed

Theriva Biologics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.